Yahoo Finance Why Bio-Rad Laboratories (BIO) Could Be Positioned for a Surge
Bio-Rad Laboratories, Inc. BIO is a leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on BIO’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Bio-Rad Laboratories could be a solid choice for investors.
Current Quarter Estimates for BIO
In the past 30 days, one estimate has gone higher for Bio-Rad Laboratories while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from $1.68 a share 30 days ago, to $1.85 today, a move of 10.1%.
Current Year Estimates for BIO
Meanwhile, Bio-Rad Laboratories’ current year figures are also looking quite promising, with one estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $7.20 per share 30 days ago to $7.90 per share today, an increase of 9.7%.
BioRad Laboratories, Inc. Price and Consensus
BioRad Laboratories, Inc. price-consensus-chart | BioRad Laboratories, Inc. Quote
Bottom Line
The stock has also started to move higher lately, adding 9.6% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So, investors may want to consider this Zacks Rank #2 (Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BioRad Laboratories, Inc. (BIO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
